Vernalis

The number of National Certificate of Registration: 77.99.23.3.U.8794.10.08 dated October 14, 2008

Specification number: TU 9283-001-59230155-07

Formulation: “Dienai C”  (salmon roe extract (low-molecular DNA), potato starch, microcrystalline cellulose, sodium chloride, polyethylene glycol), extract of root of Rhodiola quadrifida, one-sided pyrola extract, nettle extract.

Pharmacological group: refers to the group of food supplements-parapharmaceutics.

Toxicologic characteristics: This preparation refers to class 4 (“low-hazard substances”) according to Russian Interstate Standard 12.1.007-76. No toxic or side effects were revealed after the experimental intragastral administration to animals.

Indications: gynaecological disorders and morbid conditions: chronic inflammatory diseases of internal genital organs, cystic formations, fibromyomas, hysteromyomas, chronic urogenital infection, mastopathies, primary and secondary sterility, endometriosis, cervical erosion, genital candidiasis, genital herpes.

Administration method and dosage: orally, 1 capsule three times a day during the meal to adults and children older than 14 years. Administration duration is 3 weeks.

Contraindications: individual intolerance for preparation components, pregnancy, lactation, gout, and other abnormalities in purine exchange (hyperuricemy, urine acid diathesis, urate nephrolithiasis), increased nervous irritability, insomnia, hypertonia, cardiac abnormalities, marked atherosclerosis.

Pharmaceutical form: 0.5 g capsules, 70 (30) per package.

Storing conditions: store in a dry place away from light, out of the reach of children at temperature up to 25 oC.

Expiration date: 2 years from the date of manufacturing.

Prescription conditions: No prescription required.

Manufacturer: Siberian Center for Pharmacology and Biotechnology, closed joint-stock company (Novosibirsk, Russian Federation).